Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sino Biopharmaceutical Ltd (HK:1177)
:1177
Holding HK:1177?
Track your performance easily
1177 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$2.29 - HK$4.25
Previous CloseN/A
Volume63.93M
Average Volume (3M)55.98M
Market Cap
$53.70B
Enterprise ValueHK$55.37B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)19.4
Beta1.16
Next Earnings
Mar 28, 2025EPS Estimate
0.08Last Dividend Ex-Date
Sep 10, 2024Dividend Yield1.73%
Share Statistics
EPS (TTM)0.15
Shares Outstanding18,791,217,000
10 Day Avg. Volume66,580,798
30 Day Avg. Volume55,979,632
Standard Deviation0.10
R-Squared0.27
Alpha-0.00384
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.04Price Target Upside7.72% Upside
Rating ConsensusHold
Number of Analyst Covering1
Sino Biopharmaceutical News
PremiumCompany Announcements
Sino Biopharmaceutical Reports Promising Lung Cancer Study Results
PremiumCompany Announcements
Sino Biopharmaceutical Advances ASPS Treatment with New Drug Combo
PremiumCompany Announcements
Sino Biopharmaceutical’s Promising Lung Cancer Drug Results
PremiumCompany Announcements
Sino Biopharmaceutical Gains Approval for Cancer Drug
PremiumCompany Announcements
Sino Biopharm’s Strategic Alliance with Biosion and Aclaris
PremiumCompany Announcements
Sino Biopharmaceutical Gains Approval for Cancer TreatmentPremiumCompany Announcements
Sino Biopharmaceutical’s Promising Liver Cancer Treatment Advancement
PremiumCompany Announcements
Sino Biopharm Invests in LaNova for Cancer InnovationsOptions Prices
Currently, No data available
---
Ownership Overview
15.48% Insiders
2.65% Mutual Funds
<0.01% Other Institutional Investors
76.99% Public Companies and
Individual Investors
1177 FAQ
What was Sino Biopharmaceutical Ltd’s price range in the past 12 months?
Sino Biopharmaceutical Ltd lowest stock price was HK$2.29 and its highest was HK$4.25 in the past 12 months.
What is Sino Biopharmaceutical Ltd’s market cap?
Sino Biopharmaceutical Ltd’s market cap is $53.70B.
When is Sino Biopharmaceutical Ltd’s upcoming earnings report date?
Sino Biopharmaceutical Ltd’s upcoming earnings report date is Mar 28, 2025 which is in 56 days.
How were Sino Biopharmaceutical Ltd’s earnings last quarter?
Sino Biopharmaceutical Ltd released its earnings results on Aug 13, 2024. The company reported HK$0.084 earnings per share for the quarter, beating the consensus estimate of HK$0.076 by HK$0.008.
Is Sino Biopharmaceutical Ltd overvalued?
According to Wall Street analysts Sino Biopharmaceutical Ltd’s price is currently Undervalued.
Does Sino Biopharmaceutical Ltd pay dividends?
Sino Biopharmaceutical Ltd pays a Annually dividend of HK$0.029 which represents an annual dividend yield of 1.73%. See more information on Sino Biopharmaceutical Ltd dividends here
What is Sino Biopharmaceutical Ltd’s EPS estimate?
Sino Biopharmaceutical Ltd’s EPS estimate is 0.08.
How many shares outstanding does Sino Biopharmaceutical Ltd have?
Sino Biopharmaceutical Ltd has 18,791,217,000 shares outstanding.
What happened to Sino Biopharmaceutical Ltd’s price movement after its last earnings report?
Sino Biopharmaceutical Ltd reported an EPS of HK$0.084 in its last earnings report, beating expectations of HK$0.076. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sino Biopharmaceutical Ltd?
Currently, no hedge funds are holding shares in HK:1177
---
Sino Biopharmaceutical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
HK$3.04 (7.72% Upside)
HK$3.04 (7.72% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.63%
12-Months-Change
Fundamentals
Return on Equity
6.54%
Trailing 12-Months
Asset Growth
1.59%
Trailing 12-Months
Company Description
Sino Biopharmaceutical Ltd
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
---
1177 Stock 12 Month Forecast
Average Price Target
HK$3.04
▲(7.72% Upside)
Technical Analysis
Ping An Insurance Company of China
―
CSPC Pharmaceutical Group
―
Livzon Pharmaceutical Group
―
China Resources Pharmaceutical Group Ltd.
―
Huazhu Group Ltd
―
Best Analysts Covering 1177
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-18.50%
reiterated a buy rating 6 months ago
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.50% per trade.
---